News & Analysis on Clinical Trial Services & Contract Research And Development
Guava Technologies have introduced a new cell cycle assay to add to its range of personal cell analysis systems, which intends to make drug discovery applications in the areas of immunology and oncology more sensitive and accurate.
In the race to develop therapeutics based on RNA interference, Alnylam Pharmaceuticals has claimed a first with the publication of a study showing in vivo RNAi-mediated gene silencing in mammals by a method that potentially can be applied to systemic...